EMA Rejects Drugs for Rett Syndrome, Schizophrenia

Daybue was turned down for Rett syndrome, and Iloperidone for schizophrenia and bipolar I, with safety and benefit-risk concerns cited in both cases.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/ema-rejects-drugs-rett-syndrome-schizophrenia-2026a100068m?src=rss

Author :

Publish date : 2026-02-27 16:28:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

EMA Rejects Drugs for Rett Syndrome, Schizophrenia

NIH Vacancies; MA Referral Shakeup; Erase 20 Years of Nursing Board Discipline?

FDA to Offer Bonus Payments to Staffers Who Complete Speedy Drug Reviews

Related Posts

Study Warns of Large Increase in New HIV Cases in U.S. if Ryan White Program Ends

No Major ‘Reactions’ at FDA’s Food Allergy Expert Panel

EMA Backs First Combined mRNA Vaccine for COVID-19 and Flu

FDA to Offer Bonus Payments to Staffers Who Complete Speedy Drug Reviews

NIH Vacancies; MA Referral Shakeup; Erase 20 Years of Nursing Board Discipline?

Study Questions Use of Prostate Cancer Hormone Therapy in Certain Cases

Study Warns of Large Increase in New HIV Cases in U.S. if Ryan White Program Ends

No Major ‘Reactions’ at FDA’s Food Allergy Expert Panel

EMA Backs First Combined mRNA Vaccine for COVID-19 and Flu

FDA to Offer Bonus Payments to Staffers Who Complete Speedy Drug Reviews

EMA Rejects Drugs for Rett Syndrome, Schizophrenia

NIH Vacancies; MA Referral Shakeup; Erase 20 Years of Nursing Board Discipline?

Study Questions Use of Prostate Cancer Hormone Therapy in Certain Cases

Novartis Settles With Henrietta Lacks’ Estate Over Use of ‘Stolen’ Cells in Research

Categories

Archives